63
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Analysis of the characteristics and prognosis of advanced non-small-cell lung cancer in older patients

, , , , , & show all
Pages 1189-1194 | Published online: 19 Aug 2015

References

  • FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer20101272893291721351269
  • AlbergAJFordJGSametJMAmerican College of Chest Physicians. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)Chest20071323 Suppl29S55S17873159
  • IachinaMGreenAJakobsenEThe direct and indirect impact of comorbidity on the survival of patients with non-small cell lung cancer: a combination of survival, staging and resection models with missing measurements in covariatesBMJ Open20144e003846
  • SmithBDSmithGLHurriaAHortobagyiGNBuchholzTAFuture of cancer incidence in the United States: burdens upon an aging, changing nationJ Clin Oncol2009272758276519403886
  • SacherAGLeLWLeighlNBCoateLEElderly patients with advanced NSCLC in phase III clinical trials: are the elderly excluded from practice-changing trials in advanced NSCLC?J Thorac Oncol2013836636823407560
  • BlancoJAGTosteISAlvarezRFCuadradoGRGonzalvezAMMartínIJAge, comorbidity, treatment decision and prognosis in lung cancerAge Ageing20083771571819004964
  • de RijkeJMSchoutenLJVelde tenGPMInfluence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based studyLung Cancer20044623324515474672
  • StrømHHBremnesRMSundstrømSHHow do elderly poor prognosis patients tolerate palliative concurrent chemoradiotherapy for locally advanced non-small cell lung cancer stage III? a subset analysis from a clinical phase III trialClin Lung Cancer2014 S1525–7304(14)00236–8
  • RadzikowskaERoszkowskiKGłazPLung cancer in patients under 50 years oldLung Cancer20013320321111551415
  • RamalingamSPawlishKGadgeelSDemersRKalemkerianGPLung cancer in young patients: analysis of a surveillance, epidemiology, and end results databaseJ Clin Oncol1998166516579469354
  • KowalskiDMKrzakowskiMNew agents in chemotherapy of disseminated non-small cell lung cancer – real benefitsWspolczesna Onkol20015278284
  • SubramanianJMorgenszternDGoodgameBDistinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysisJ Thorac Oncol20105232819934774
  • YeTPanYWangRAnalysis of the molecular and clinicopatho-logic features of surgically resected lung adenocarcinoma in patients under 40 years oldJ Thorac Dis20146101396140225364516
  • WeissJLangerCTreatment of lung cancer in the elderly patientSemin Respir Crit Care Med20133480280924258570
  • DavidoffAJTangMSealBEdelmanMJChemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancerJ Clin Oncol2010282191219720351329
  • BeckettPCallisterMTataLJClinical management of older people with non-small cell lung cancer in EnglandThorax20126783683922771514
  • MeoniGCecereFLLucheriniEDi CostanzoFMedical treatment of advanced non-small cell lung cancer in elderly patients: a review of the role of chemotherapy and targeted agentsJ Geriatr Oncol2013428229024070465
  • GridelliCLung cancer: locally advanced NSCLC in the elderly: which treatment?Nat Rev Clin Oncol2012943443522777057
  • WisniveskyJPStraussGMTreating elderly patients with stage III NSCLCLancet Oncol20121365065122622009
  • MaionePRossiASaccoPCBareschinoMASchettinoCTreating advanced non-small cell lung cancer in the elderlyTher Adv Med Oncol2010225126021789138
  • GoreEMovsasBSantana-DavilaRLangerCEvaluation and management of elderly patients with lung cancerSemin Radiat Oncol20122230431022985813
  • AtagiSKawaharaMYokoyamaAThoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301)Lancet Oncol20121367167822622008
  • National Cancer InstituteCancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events. Version 3.0. DCTD, NCI, NIH, NHHHRockvilleNational Cancer Institute Available from: http://cteo.cancer.govAccessed March 31, 2003
  • GoodheartMJacobsonGSmithBJZhouLChemoradiation for invasive cervical cancer in elderly patients: outcomes and morbidityInt J Gynecol Cancer20081819510317466049
  • WrightJDGibbRKGeevargheseSCervical carcinoma in the elderly: an analysis of patterns of care and outcomeCancer20051031859115540239
  • GaoYMaJLGaoFSongLPThe evaluation of older patients with cervical cancerClin Interv Aging2013878378823836968
  • D’AddarioGPintilieMLeighlNBFeldRCernyTShepherdFAPlatinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literatureJ Clin Oncol2005232926293615728229
  • GridelliCGalloCShepherdFAGemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials GroupJ Clin Oncol2003213025303412837810
  • SchillerJHHarringtonDBelaniCPComparison of four chemotherapy regimens for advanced non-small cell lung cancerN Engl J Med2002346929811784875
  • GridelliCRossiAMaionePChallenges treating older non-small cell lung cancer patientsAnn Oncol200819suppl 7vii109vii11318790931
  • LeppertWTurskaAMajkowiczMDziegielewskaSPankiewiczPMessEQuality of life in patients with advanced lung cancer treated at home and at a palliative care unitAm J Hosp Palliat Care20122937938722057209
  • AlexaTLaviniaALucaAMironLAlexaIDIncidence of chemotherapy discontinuation and characteristics of elderly patients with non-small cell lung cancer treated with platinum-based doubletsContemp Oncol (Pozn)20141834034325477757
  • FarbickaPNowickiAPalliative care in patients with lung cancerContemp Oncol201317238245